[{"Assets_0_Q2_USD":2597136000.0,"CommonStockSharesOutstanding_0_Q2_shares":48584123.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":48536000.0,"NetIncomeLoss_1_Q2_USD":15066000.0,"NetIncomeLoss_2_Q2_USD":28339000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":49338000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":49263000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":48487000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":48406000.0,"StockholdersEquity_0_Q2_USD":1783034000.0,"EarningsPerShareBasic_1_Q2_USD":0.31,"EarningsPerShareBasic_2_Q2_USD":0.59,"EarningsPerShareDiluted_1_Q2_USD":0.31,"EarningsPerShareDiluted_2_Q2_USD":0.58,"Ticker":"LIVN","CIK":"1639691","name":"LIVANOVA PLC","OfficialName":"LivaNova PLC Ordinary Shares","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4559360993.0","Country":"United Kingdom","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20180802"}]